SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

75,577.58 -555.23
( -0.73%)

Global Indices

Nasdaq

53,435.25 -271.85
(-0.51%)

Dow Jones

7,739.60 -29.11
(-0.37%)

Hang Seng

65,678.73 -721.11
(-1.09%)

Nikkei 225

10,811.26 -10.87
(-0.10%)

Forex

USD-INR

94.44 -0.05
(-0.05%)

EUR-INR

109.67 -0.05
(-0.04%)

GBP-INR

127.62 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ipca Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524494

INE571A01038

314.5139046

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IPCALAB

39.26

49704.46

EPS(TTM)

Face Value()

Div & Yield %

49.9

0.31

Back

suditi industries ltd

UPL reports consolidated net profit of Rs 10.00 crore in the June 2026 quarter

Aug 03,2026

Net profit of UPL reported to Rs 10.00 crore in the quarter ended June 2026 as against net loss of Rs 88.00 crore during the previous quarter ended June 2025. Sales rose 10.47% to Rs 10181.00 crore in the quarter ended June 2026 as against Rs 9216.00 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	10181.00	9216.00	10
OPM %	13.43	15.15	-
PBDT	732.00	550.00	33
PBT	-100.00	-181.00	45
NP	10.00	-88.00	LP

75,577.58 -555.23 ( -0.73%)

53,435.25 -271.85 (-0.51%)

7,739.60 -29.11 (-0.37%)

65,678.73 -721.11 (-1.09%)

10,811.26 -10.87 (-0.10%)

94.44 -0.05 (-0.05%)

109.67 -0.05 (-0.04%)

127.62 -0.01 (-0.01%)

0.60 0.00 (0.12%)